Trial Profile
IL-6 Regulation of Substrate Metabolism and Influence of Obesity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 20 Apr 2022 Results determining the role of IL-6 in regulating systemic protein and amino acid metabolism during rest, exercise and recovery in lean and obese humans, published in the Journal of Clinical Endocrinology and Metabolism
- 06 Oct 2020 Status changed from recruiting to completed.
- 23 Sep 2019 Status changed from not yet recruiting to recruiting.